OM
Outset Medical Inc
4.00$
+5.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 311.1% | 255.6% | 301.3% | 139.2% | 149.6% | 140.6% | 137.3% | 97.6% | 98.7% | 95.8% | 88.8% | 88.2% | 85.5% | 84.9% | 84.4% | 83.5% | 80.8% | 78.6% | 76.4% | 74.7% | 70.8% | 64.3% | 65.7% | 63.5% | 62.8% | 62.2% | 60.6% | 57.6% | 56.6% | 58.0% | 58.2% | |
| -211.1% | -155.6% | -201.3% | -39.2% | -49.6% | -40.6% | -37.3% | 2.4% | 1.3% | 4.2% | 11.2% | 11.8% | 14.5% | 15.1% | 15.6% | 16.5% | 19.2% | 21.4% | 23.6% | 25.3% | 29.2% | 35.7% | 34.3% | 36.5% | 37.2% | 37.8% | 39.4% | 42.4% | 43.4% | 42.0% | 41.8% | |
| 217.1% | 194.4% | 217.0% | 93.6% | 81.2% | 51.5% | 66.7% | 45.1% | 33.0% | 31.9% | 37.0% | 40.5% | 35.5% | 54.0% | 47.0% | 35.8% | 41.2% | 41.4% | 52.9% | 41.1% | 44.9% | 35.5% | 28.4% | 26.8% | 18.5% | 16.8% | 18.3% | 17.5% | 20.2% | 17.2% | 18.2% | |
| 80.9% | 76.1% | 92.7% | 32.2% | 49.0% | 41.3% | 95.1% | 52.5% | 40.3% | 38.6% | 29.0% | 34.5% | 31.8% | 43.0% | 36.0% | 31.3% | 35.2% | 31.3% | 38.9% | 33.9% | 40.6% | 46.3% | 35.2% | 31.4% | 27.9% | 29.2% | 28.8% | 41.3% | 36.3% | 35.9% | 35.5% | |
| 435.4% | 425.8% | 500.2% | 222.9% | 231.5% | 171.6% | 258.8% | 185.7% | 130.8% | 122.8% | 125.7% | 156.7% | 133.9% | 189.6% | 163.3% | 140.9% | 149.1% | 142.0% | 173.3% | 147.7% | 160.2% | 148.0% | 117.4% | 110.7% | 92.3% | 91.4% | 93.1% | 103.4% | 104.1% | 91.5% | 97.8% | |
| -663.9% | -583.2% | -701.5% | -262.1% | -281.1% | -212.1% | -296.1% | -183.3% | -129.5% | -118.6% | -114.5% | -144.9% | -119.4% | -174.5% | -147.7% | -124.4% | -129.9% | -120.6% | -149.7% | -122.4% | -131.0% | -112.3% | -83.2% | -74.2% | -55.1% | -53.7% | -53.7% | -61.1% | -60.7% | -49.6% | -56.1% | |
| – | – | 39.8% | 14.4% | 13.9% | 8.8% | 3.1% | 2.5% | 1.8% | 1.7% | 1.6% | 1.5% | 1.4% | 1.9% | 2.0% | 6.5% | 8.8% | 8.6% | 10.6% | 11.2% | 21.2% | 21.9% | 21.2% | 19.8% | 12.0% | 11.1% | 11.8% | 11.9% | 12.1% | 10.9% | 11.7% | |
| -659.3% | -592.9% | -584.9% | -274.5% | -287.2% | -225.7% | -307.5% | -185.8% | -130.9% | -119.7% | -115.8% | -146.0% | -120.4% | -174.6% | -146.8% | -129.3% | -130.8% | -121.8% | -151.8% | -126.2% | -141.2% | -125.2% | -96.8% | -87.0% | -86.3% | -58.7% | -59.2% | -67.2% | -67.3% | -56.2% | -62.3% | |
| 315.9% | 279.5% | 0.8% | 14.4% | 13.9% | 8.8% | 3.1% | -11.2% | 0.2% | 0.1% | -4.6% | 0.4% | 0.4% | 0.4% | 0.1% | 0.2% | 0.6% | 0.4% | 0.3% | 0.4% | 0.6% | 0.6% | 0.6% | 0.0% | 0.4% | 0.3% | 1.4% | 0.3% | 0.8% | 0.7% | 0.8% | |
| -975.2% | -872.5% | -585.6% | -274.5% | -287.2% | -225.7% | -307.5% | -185.8% | -131.0% | -119.8% | -115.8% | -146.5% | -120.8% | -175.0% | -146.9% | -129.5% | -131.4% | -122.2% | -152.1% | -126.5% | -141.8% | -125.8% | -97.5% | -87.0% | -86.7% | -59.0% | -60.6% | -67.5% | -68.1% | -56.8% | -63.1% | |
| -648.7% | -570.1% | -540.1% | -248.5% | -269.0% | -212.8% | -301.2% | -172.1% | -123.6% | -112.8% | -109.1% | -138.9% | -114.9% | -166.3% | -139.0% | -117.9% | -117.0% | -108.2% | -135.4% | -110.2% | -114.9% | -97.9% | -68.2% | -62.5% | -50.8% | -43.9% | -46.3% | -52.2% | -52.4% | -40.8% | -47.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.